发明名称 |
MODULATION OF T LYMPHOCYTES USING DP IV INHIBITORS |
摘要 |
The present invention discloses a method for therapeutically treating mammals, including but not limited to humans, to modulate immune responses via modulation of surface expression of co-stimulatory antigens on T lymphocytes. oral administration of a DP IV inhibitor causes a potent immunosuppressive effect. This immunosuppressive effect of DP IV inhibitors is exerted by an enhancement of CTLA-4 surface expression, with simultaneous inhibition of CD28 surface expression, on T cells. Furthermore, the present invention discloses preparation of a medicament, comprising one or more inhibitors of dipeptidyl peptidase enzymatic activity, for the treatment of immune disorders such as allograft rejection or autoimmune disease. |
申请公布号 |
WO03063903(A2) |
申请公布日期 |
2003.08.07 |
申请号 |
WO2003EP01044 |
申请日期 |
2003.02.03 |
申请人 |
PROBIODRUG AG;HOFFMANN, TORSTEN;HILDEBRANDT, MARTIN;DEMUTH, HANS-ULRICH |
发明人 |
HOFFMANN, TORSTEN;HILDEBRANDT, MARTIN;DEMUTH, HANS-ULRICH |
分类号 |
A61K31/40;A61K38/55 |
主分类号 |
A61K31/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|